Sprenger Lab
The Sprenger Rationally Designed Immunotherapeutics & Interfaces (RDI) Research Group employs modern computational techniques to tackle big problems, from infectious diseases to climate change. This includes molecular simulation, mathematical modeling, and machine learning techniques to describe complex interfacial phenomena, such as pathogen-antibody (for vaccine design) and small molecule-cell membrane (for treating brain-based diseases).Ìı